Clinical Trial Update: Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the combination of pamidronate and thalidomide for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Aredia (pamidronate disodium)
• Thalomid (thalidomide)

Snippet

Sponsor: University of Arkansas | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED